Stock listing
NASDAQ:AHG Akso Health Group Stock
Follow Akso Health Group into a list and get an email when it puts out news.
Share price · NASDAQ:AHG
$1.26 USD -0.10 (-7.3%)
Close on Nov 20, 2026
- Day range
- $1.24 – $1.30 USDNov 20, 2026
- Volume
- 8,563 sharesNov 20, 2026
- Market cap
- $1.08B USDAt the close on Nov 20, 2026 · price × 854.0M shares outstanding
- 52-week range
- $0.681 – $2.50 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $96,143 USDMedian day 7,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:AHG · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.26 | -0.099 | -7.3% | $1.30 | $1.30 | $1.24 | 8,563 | |
| $1.359 | +0.119 | +9.6% | $1.359 | $1.359 | $1.359 | 1,667 | |
| $1.24 | -0.09 | -6.8% | $1.319 | $1.319 | $1.24 | 2,457 | |
| $1.33 | +0.09 | +7.3% | $1.315 | $1.33 | $1.315 | 1,489 | |
| $1.24 | -0.105 | -7.8% | $1.248 | $1.248 | $1.24 | 2,549 | |
| $1.345 | -0.005 | -0.4% | $1.345 | $1.345 | $1.345 | 1,418 | |
| $1.35 | +0.101 | +8.1% | $1.33 | $1.355 | $1.28 | 13,452 | |
| $1.249 | -0.031 | -2.5% | $1.295 | $1.388 | $1.20 | 7,100 | |
| $1.28 | -0.07 | -5.2% | $1.23 | $1.39 | $1.23 | 7,146 | |
| $1.35 | +0.055 | +4.2% | $1.30 | $1.37 | $1.29 | 13,326 | |
| $1.295 | -0.035 | -2.6% | $1.295 | $1.295 | $1.295 | 964 | |
| $1.33 | +0.12 | +9.9% | $1.26 | $1.38 | $1.26 | 8,621 | |
| $1.21 | -0.103 | -7.8% | $1.24 | $1.24 | $1.168 | 2,732 | |
| $1.313 | +0.052 | +4.2% | $1.23 | $1.313 | $1.23 | 2,948 | |
| $1.26 | -0.07 | -5.3% | $1.25 | $1.27 | $1.24 | 4,606 | |
| $1.33 | +0.03 | +2.3% | $1.30 | $1.37 | $1.28 | 33,100 | |
| $1.30 | -0.11 | -7.8% | $1.29 | $1.40 | $1.25 | 106,800 | |
| $1.41 | +0.14 | +11.0% | $1.27 | $1.50 | $1.27 | 11,300 | |
| $1.27 | -0.03 | -2.3% | $1.24 | $1.27 | $1.16 | 6,400 | |
| $1.30 | +0.08 | +6.6% | $1.30 | $1.30 | $1.25 | 1,900 | |
| $1.22 | -0.05 | -3.9% | $1.25 | $1.285 | $1.21 | 7,000 | |
| $1.27 | +0.043 | +3.5% | $1.366 | $1.366 | $1.21 | 4,800 | |
| $1.227 | -0.103 | -7.7% | $1.24 | $1.369 | $1.22 | 7,700 | |
| $1.33 | -0.02 | -1.5% | $1.27 | $1.33 | $1.22 | 1,900 | |
| $1.35 | 0.00 | 0.0% | $1.34 | $1.39 | $1.225 | 3,600 | |
| $1.35 | -0.025 | -1.8% | $1.37 | $1.37 | $1.348 | 2,100 | |
| $1.375 | +0.016 | +1.2% | $1.39 | $1.44 | $1.308 | 9,200 | |
| $1.359 | -0.011 | -0.8% | $1.41 | $1.445 | $1.291 | 8,900 | |
| $1.37 | +0.12 | +9.6% | $1.23 | $1.455 | $1.17 | 25,500 | |
| $1.25 | +0.11 | +9.6% | $1.08 | $1.25 | $1.08 | 21,100 | |
| $1.14 | -0.07 | -5.8% | $1.17 | $1.21 | $1.11 | 8,200 | |
| $1.21 | +0.04 | +3.4% | $1.17 | $1.22 | $1.11 | 16,800 | |
| $1.17 | +0.01 | +0.9% | $1.18 | $1.18 | $1.12 | 20,000 | |
| $1.16 | +0.01 | +0.9% | $1.125 | $1.17 | $1.07 | 29,200 | |
| $1.15 | +0.13 | +12.7% | $1.07 | $1.15 | $1.02 | 82,000 | |
| $1.02 | +0.12 | +13.3% | $0.808 | $1.03 | $0.78 | 237,400 | |
| $0.90 | +0.209 | +30.2% | $0.745 | $1.03 | $0.735 | 5,643,300 | |
| $0.691 | -0.04 | -5.5% | $0.759 | $0.809 | $0.681 | 32,900 | |
| $0.731 | -0.019 | -2.5% | $0.73 | $0.801 | $0.70 | 48,100 | |
| $0.75 | -0.01 | -1.3% | $0.764 | $0.77 | $0.75 | 2,400 | |
| $0.76 | -0.01 | -1.3% | $0.737 | $0.838 | $0.73 | 11,500 | |
| $0.77 | +0.03 | +4.1% | $0.732 | $0.79 | $0.73 | 3,900 | |
| $0.74 | -0.02 | -2.6% | $0.74 | $0.743 | $0.74 | 1,100 | |
| $0.76 | +0.009 | +1.2% | $0.78 | $0.78 | $0.74 | 4,200 | |
| $0.751 | +0.001 | +0.1% | $0.769 | $0.84 | $0.751 | 8,800 | |
| $0.75 | +0.005 | +0.7% | $0.745 | $0.789 | $0.745 | 3,000 | |
| $0.745 | -0.015 | -2.0% | $0.85 | $0.85 | $0.73 | 9,700 | |
| $0.76 | -0.042 | -5.2% | $0.78 | $0.805 | $0.752 | 5,500 | |
| $0.802 | -0.037 | -4.4% | $0.809 | $0.85 | $0.781 | 7,500 | |
| $0.839 | +0.109 | +14.9% | $0.75 | $0.84 | $0.74 | 13,300 | |
| $0.73 | -0.07 | -8.8% | $0.78 | $0.815 | $0.73 | 125,400 | |
| $0.80 | -0.017 | -2.1% | $0.899 | $0.899 | $0.80 | 1,000 | |
| $0.817 | -0.031 | -3.7% | $0.858 | $0.904 | $0.801 | 22,200 | |
| $0.848 | -0.026 | -3.0% | $0.874 | $0.959 | $0.848 | 2,600 | |
| $0.874 | +0.024 | +2.8% | $0.864 | $0.96 | $0.864 | 11,400 | |
| $0.85 | -0.05 | -5.6% | $0.84 | $0.90 | $0.84 | 12,400 | |
| $0.90 | 0.00 | 0.0% | $0.86 | $0.94 | $0.84 | 2,200 | |
| $0.90 | +0.043 | +5.0% | $0.97 | $0.97 | $0.84 | 6,200 | |
| $0.857 | -0.123 | -12.6% | $0.91 | $0.955 | $0.851 | 15,900 | |
| $0.98 | -0.01 | -1.0% | $0.99 | $0.99 | $0.97 | 8,100 | |
| $0.99 | +0.006 | +0.6% | $0.965 | $0.99 | $0.955 | 3,200 | |
| $0.984 | +0.041 | +4.3% | $0.916 | $0.99 | $0.916 | 6,800 | |
| $0.943 | +0.013 | +1.4% | $0.99 | $0.99 | $0.901 | 3,700 | |
| $0.93 | -0.09 | -8.8% | $0.99 | $0.99 | $0.905 | 11,100 | |
| $1.02 | +0.053 | +5.5% | $1.07 | $1.15 | $1.01 | 15,000 |
Splits
1 split · NASDAQ:AHG · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-3 | Consolidation |
- Ticker
- NASDAQ:AHG
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Valuation
Statements: Year to Mar 31, 2026 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.08B USD
- P/E
- Loss
- EV/sales
- 77.8×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 6.0×
- Gross margin
- −0.1%
- Operating margin
- −149.7%
- Net margin
- −135.0%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.19
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Oct 22, 2026 | +2.4% |
| Q3 2026 | Feb 10, 2026 | −4.7% |
| Q2 2026 | Nov 4, 2025 | +6.3% |
| Q1 2026 | Aug 14, 2025 | +1.8% |
| Q4 2025 | Jun 17, 2025 | +1.4% |
| Q3 2025 | Feb 28, 2025 | +0.7% |
| Q1 2025 | Sep 18, 2024 | +22.3% |
| Q4 2024 | Jun 18, 2024 | 0.0% |
| Q3 2024 | Jan 11, 2024 · After close | +20.2% |
| Q2 2024 | Dec 18, 2023 | +23.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Sep 20, 2023 | −3.7% |
| Q4 2023 | Jun 20, 2023 | −6.8% |
| Q3 2023 | Mar 2, 2023 | −6.3% |
| Q2 2023 | Dec 19, 2022 | −9.3% |
| Q1 2023 | Sep 21, 2022 | −4.7% |
| Q4 2022 | Jun 21, 2022 | −4.4% |
| Q3 2022 | Mar 3, 2022 | −4.1% |
| Q2 2022 | Dec 20, 2021 | +4.3% |
| Quarter to Jun 30, 2021 | Sep 15, 2021 | 0.0% |
| Quarter to Mar 31, 2021 | Jun 15, 2021 | −12.9% |
IPO
Went public as Hexindai Inc. Final prospectus filed on Oct 25, 2017.
- Listing
- HX on the Nasdaq Global Market
- Underwriter
- Network 1 Financial Securities, Inc.
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Apr 7, 2017 |
| Filed publicly | Sep 29, 2017 |
| Amended once | Oct 16, 2017 |
| Shares registered with an exchange | Oct 16, 2017 |
| Declared effective by the SEC | Oct 24, 2017 |
| Final prospectus, with the price | Oct 25, 2017 |
Filings
| Filing | Filed |
|---|---|
| CERTNAS · Nasdaq's certificate of listing | Nov 2, 2017 |
| 424B4 · Prospectus | Oct 25, 2017 |
| EFFECT · Notice that a registration is effective | Oct 24, 2017 |
| CORRESP · Letter to the SEC | Oct 24, 2017 |
| CORRESP · Letter to the SEC | Oct 20, 2017 |
| CORRESP · Letter to the SEC | Oct 20, 2017 |
| CORRESP · Letter to the SEC | Oct 20, 2017 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 16, 2017 |
| CORRESP · Letter to the SEC | Oct 16, 2017 |
| F-1/A · Registration statement, amended | Oct 16, 2017 |
All 29 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Sep 29, 2017 |
| F-1 · Registration statement | Sep 29, 2017 |
| DRSLTR · Letter to the SEC with a draft | Sep 19, 2017 |
| DRS/A · Draft registration statement, amended | Sep 19, 2017 |
| UPLOAD · Letter from the SEC | Sep 12, 2017 |
| DRSLTR · Letter to the SEC with a draft | Aug 28, 2017 |
| DRS/A · Draft registration statement, amended | Aug 28, 2017 |
| UPLOAD · Letter from the SEC | Aug 15, 2017 |
| DRSLTR · Letter to the SEC with a draft | Aug 1, 2017 |
| DRS/A · Draft registration statement, amended | Aug 1, 2017 |
| UPLOAD · Letter from the SEC | Jul 21, 2017 |
| DRSLTR · Letter to the SEC with a draft | Jul 6, 2017 |
| DRS/A · Draft registration statement, amended | Jul 6, 2017 |
| UPLOAD · Letter from the SEC | Jun 9, 2017 |
| DRSLTR · Letter to the SEC with a draft | May 25, 2017 |
| DRS/A · Draft registration statement, amended | May 25, 2017 |
| UPLOAD · Letter from the SEC | May 4, 2017 |
| DRSLTR · Letter to the SEC with a draft | Apr 7, 2017 |
| DRS · Draft registration statement | Apr 7, 2017 |
Open IPO · From the cover of the final prospectus (424B4) filed Oct 25, 2017
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.8M | 14.8M | 2.41M | 13.2M | 6.00M | 1.75M | 6.91M | 3.70M | 107.3M | 22.9M |
| Cost of revenue | 13.8M | 15.1M | 2.29M | 11.9M | 5.39M | 544.6K | 1.03M | 7.40M | 8.50M | 5.15M |
| Gross profit | -11.3K | -281.5K | 122.1K | 1.27M | 605.1K | 1.75M | 6.91M | 53.9M | 107.3M | 22.9M |
| Research and development | 4 | 421.2K | 421.2K | 441.4K | 117.9K | 0 | 2.82M | 1.57M | ||
| Selling, general and administrative | 3.99M | 3.64M | 8.59M | 15.5M | 15.4M | 2.03M | 20.8M | 16.5M | 7.64M | 2.65M |
| Operating income | -20.7M | -166.3M | -8.64M | -14.3M | -3.26M | -4.24M | -48.1M | -7.19M | 75.9M | 9.91M |
| Depreciation and amortization | 2.37M | 2.15M | 0 | 18.4K | 18.4K | 15.2K | 120.5K | 17.2K | 174.4K | 92.2K |
| EBITDA | -18.3M | -164.2M | -8.64M | -14.2M | -3.24M | -4.23M | -48.0M | -7.17M | 76.0M | 10.0M |
| Interest expense | 0 | 804.1K | 804.1K | 2.15M | 2.50M | 0 | 0 | |||
| Income before tax | -20.7M | -166.3M | -9.09M | -13.1M | -4.01M | -4.29M | -46.9M | -6.81M | 76.5M | 10.1M |
| Income tax | -1.99M | -30.8M | 25.0K | 17.5K | 92.8K | 483.0K | 490.0K | 807.7K | 11.0M | 1.52M |
| Net income | -18.7M | -135.0M | -9.46M | -1.36M | -16.9M | -34.8M | -71.2M | 5.53M | 65.5M | 8.57M |
| Earnings per share, basic | 0.01 | 0.16 | 0.07 | -0.02 | -0.28 | -0.71 | -1.46 | 0.11 | 1.46 | 0.20 |
| Earnings per share, diluted | 0.01 | 0.16 | 0.07 | -0.02 | -0.28 | -0.71 | -1.46 | 0.10 | 1.37 | 0.20 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 170.6K | 176.2M | 85.2M | 7.92M | 18.4M | 15.1M | 6.67M | 57.4M | 132.6M | 19.2M |
| Receivables | 1.28M | 954.2K | 56.3M | 7.70M | 20.0M | 14.4M | 36.3M | 140.6K | 0 | 2.17M |
| Inventory | 200.1K | 190.2K | 191.2K | 1.69M | 7.80M | -14.4M | -39.0B | -2.08M | 1 | 28.5M |
| Current assets | 189.5M | 196.1M | 142.0M | 20.5M | 62.8M | 30.1M | 52.0M | 97.7M | 163.1M | 27.6M |
| Property, plant and equipment | 12.0K | 16.1K | 55.4K | 66.9K | 92.8K | 1.25M | 767.1K | 427.9K | ||
| Goodwill | 0 | 10.8M | 0 | |||||||
| Total assets | 189.6M | 215.0M | 142.0M | 20.5M | 62.8M | 50.7M | 80.5M | 173.3M | 163.9M | 28.4M |
| Accounts payable | -2.00M | -9.69M | ||||||||
| Current liabilities | 8.71M | 13.8M | 3.59M | 11.6M | 50.5M | 14.4M | 12.4M | 26.6M | 23.8M | 4.88M |
| Long-term debt | 20.0M | 20.0M | ||||||||
| Total debt | 375.7K | 81.7K | 2.00M | 9.69M | 10.0M | 20.8M | 20.0M | |||
| Total liabilities | 8.71M | 15.8M | 3.59M | 11.6M | 50.5M | 14.4M | 32.4M | 46.8M | 23.8M | 4.88M |
| Shareholders' equity | 180.9M | 199.1M | 138.4M | 8.73M | 12.3M | 17.3M | 48.1M | 126.5M | 140.0M | 23.5M |
| Shares outstanding | 722.7M | 1.66B | 437.2M | 68.6M | 68.6M | 48.9M | 48.8M | 49.2M | 48.0M | 42.9M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -12.8M | 1.18M | 1.35M | -3.25M | -8.63M | 10.1M | -58.3M | -1.73M | 87.7M | 8.19M |
| Capital spending | -1.64K | -154.5K | 0 | -4.86K | -4.86K | -4.86K | -200.4K | -7.59K | -456.0K | -287.8K |
| Free cash flow | -12.8M | 1.02M | 1.35M | -3.25M | -8.63M | 10.1M | -58.5M | -1.74M | 87.3M | 7.90M |
| Cash from investing | -163.5M | -105.9M | -54.7M | 18.5M | -20.0M | -662 | 12.8M | -68.1M | -27.6M | -287.8K |
| Cash from financing | 350.0K | 195.9M | 131.7M | -27.5M | 34.8M | -9.04M | -1.55M | -29.4K | 47.5M | 4.29M |
| Dividends paid | 0 | 0 | -19.5M | -19.5M | ||||||
| Share buybacks | 0 | 0 | -2.67M | -1.32M | ||||||
| Change in cash | -176.1M | 90.0M | 77.0M | -12.7M | 6.80M | 4.20M | -46.4M | -75.3M | 113.4M | 11.4M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 20-F · Annual report | Jul 23, 2026 | Annual report | SEC |
| 6-K · Report of a foreign issuer | May 13, 2026 | Current report | SEC |
| 3 · Initial statement of ownership | Apr 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 30, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 27, 2026 | Insider trade | SEC |
| 6-K · Report of a foreign issuer | Mar 23, 2026 | Current report | SEC |
| 3 · Initial statement of ownership | Mar 18, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 18, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 18, 2026 | Insider trade | SEC |
| 6-K · Report of a foreign issuer | Feb 10, 2026 | Current report | SEC |
All 195 filings
Cap table
Built by 6ix from Akso Health Group’s releases
- Common shares
- 854,043,910
- Fully diluted
- 854,043,910
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 854,043,910 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 854,043,910 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Stephen Brown Other companies: SolarMax Technology Inc. (CFO · Since at least Feb 12, 2024); STAAR Surgical Company (VP, Chief Financial Officer · Sep 9, 2013 – Apr 28, 2017 · Past) | Director · Since at least Mar 18, 2026 |
| Zhongliang Xie Other companies: Singularity Future Technology Ltd. (Director · Jul 31, 2023 – Jul 31, 2023 · Past) | Director · Since at least Apr 6, 2026 |
| Jianqiang Xu | Director · Since at least Mar 30, 2026 |
| Wenjuan Liu | Director · Since at least Mar 27, 2026 |
| Yilin Wang | Director · Since at least Mar 18, 2026 |
| Zhe Liu | Director · Since at least Mar 18, 2026 |
Log in to ask 6ix AI your own questions about Akso Health Group.